Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes - Leurs, PB; Stolk, RP; Hamulyak, K (Diabetes Care, 2002)